164 related articles for article (PubMed ID: 16439449)
1. Perinatal glucocorticoid treatment disrupts the hypothalamo-lactotroph axis in adult female, but not male, rats.
McArthur S; Siddique ZL; Christian HC; Capone G; Theogaraj E; John CD; Smith SF; Morris JF; Buckingham JC; Gillies GE
Endocrinology; 2006 Apr; 147(4):1904-15. PubMed ID: 16439449
[TBL] [Abstract][Full Text] [Related]
2. Perinatal glucocorticoid treatment produces molecular, functional, and morphological changes in the anterior pituitary gland of the adult male rat.
Theogaraj E; John CD; Christian HC; Morris JF; Smith SF; Buckingham JC
Endocrinology; 2005 Nov; 146(11):4804-13. PubMed ID: 16099861
[TBL] [Abstract][Full Text] [Related]
3. Altered mesencephalic dopaminergic populations in adulthood as a consequence of brief perinatal glucocorticoid exposure.
McArthur S; McHale E; Dalley JW; Buckingham JC; Gillies GE
J Neuroendocrinol; 2005 Aug; 17(8):475-82. PubMed ID: 16011483
[TBL] [Abstract][Full Text] [Related]
4. Time-specific effects of perinatal glucocorticoid treatment on anterior pituitary morphology, annexin 1 expression and adrenocorticotrophic hormone secretion in the adult female rat.
John CD; Theogaraj E; Christian HC; Morris JF; Smith SF; Buckingham JC
J Neuroendocrinol; 2006 Dec; 18(12):949-59. PubMed ID: 17076770
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II AT1A receptor mRNA expression is induced by estrogen-progesterone in dopaminergic neurons of the female rat arcuate nucleus.
Jöhren O; Sanvitto GL; Egidy G; Saavedra JM
J Neurosci; 1997 Nov; 17(21):8283-92. PubMed ID: 9334403
[TBL] [Abstract][Full Text] [Related]
6. The size and distribution of midbrain dopaminergic populations are permanently altered by perinatal glucocorticoid exposure in a sex- region- and time-specific manner.
McArthur S; McHale E; Gillies GE
Neuropsychopharmacology; 2007 Jul; 32(7):1462-76. PubMed ID: 17164817
[TBL] [Abstract][Full Text] [Related]
7. The reduction of circulating growth hormone and prolactin in streptozocin-induced diabetic male rats is possibly caused by hypothalamic rather than pituitary changes.
Boujon CE; Bestetti GE; Abramo F; Locatelli V; Rossi GL
J Endocrinol; 1995 Apr; 145(1):19-26. PubMed ID: 7798026
[TBL] [Abstract][Full Text] [Related]
8. The importance of dopamine in the pathogenesis of experimental prolactinomas.
el-Azouzi M; Hsu DW; Black PM; Jolesz F; Hedley-Whyte ET; Klibanski A; Zervas NT
J Neurosurg; 1990 Feb; 72(2):273-81. PubMed ID: 1967303
[TBL] [Abstract][Full Text] [Related]
9. Lack of prolactin receptor signaling in mice results in lactotroph proliferation and prolactinomas by dopamine-dependent and -independent mechanisms.
Schuff KG; Hentges ST; Kelly MA; Binart N; Kelly PA; Iuvone PM; Asa SL; Low MJ
J Clin Invest; 2002 Oct; 110(7):973-81. PubMed ID: 12370275
[TBL] [Abstract][Full Text] [Related]
10. A trophoblast-specific factor(s) suppresses circulating prolactin levels and increases tyrosine hydroxylase activity in tuberoinfundibular dopaminergic neurons.
Arbogast LA; Soares MJ; Tomogane H; Voogt JL
Endocrinology; 1992 Jul; 131(1):105-13. PubMed ID: 1351837
[TBL] [Abstract][Full Text] [Related]
11. Effect of neonatal treatment with monosodium glutamate on dopaminergic and L-DOPA-ergic neurons of the medial basal hypothalamus and on prolactin and MSH secretion of rats.
Bodnár I; Göõz P; Okamura H; Tóth BE; Vecsernyé M; Halász B; Nagy GM
Brain Res Bull; 2001 Aug; 55(6):767-74. PubMed ID: 11595361
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic dopaminergic neurons in transgenic dwarf mice: histofluorescence, immunocytochemical, and in situ hybridization studies.
Phelps CJ; Carlson S; Hurley DL
Anat Rec; 1991 Dec; 231(4):446-56. PubMed ID: 1686535
[TBL] [Abstract][Full Text] [Related]
13. Feedback effects of placental lactogens on prolactin levels and Fos-related antigen immunoreactivity of tuberoinfundibular dopaminergic neurons in the arcuate nucleus during pregnancy in the rat.
Lee Y; Voogt JL
Endocrinology; 1999 May; 140(5):2159-66. PubMed ID: 10218967
[TBL] [Abstract][Full Text] [Related]
14. Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release.
Bodnár I; Hechtl D; Székács D; Oláh M; Nagy GM
Ideggyogy Sz; 2007 Mar; 60(3-4):177-81. PubMed ID: 17451064
[TBL] [Abstract][Full Text] [Related]
15. The Intermediate lactotroph: a morphologically distinct, ghrelin-responsive pituitary cell in the dwarf (dw/dw) rat.
Huerta-Ocampo I; Christian HC; Thompson NM; El-Kasti MM; Wells T
Endocrinology; 2005 Nov; 146(11):5012-23. PubMed ID: 16055430
[TBL] [Abstract][Full Text] [Related]
16. Morphofunctional study of the effects of fetal exposure to cyproterone acetate on the hypothalamo-pituitary-gonadal axis of adult rats.
Rossi GL; Bestetti GE; Reymond MJ; Lemarchand-Béraud T
Exp Brain Res; 1991; 83(2):349-56. PubMed ID: 1673659
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporters participate in the physiological regulation of prolactin.
Demaria JE; Nagy GM; Lerant AA; Fekete MI; Levenson CW; Freeman ME
Endocrinology; 2000 Jan; 141(1):366-74. PubMed ID: 10614659
[TBL] [Abstract][Full Text] [Related]
18. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
19. The trophic effects of oestrogen on male rat anterior pituitary lactotrophs.
Nolan LA; Levy A
J Neuroendocrinol; 2009 May; 21(5):457-64. PubMed ID: 19302189
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of fos-related antigens (FRAs) in the hypothalamic dopaminergic neurons after immunoneutralization of endogenous prolactin.
Lerant AA; DeMaria JE; Freeman ME
Endocrine; 2001 Dec; 16(3):181-7. PubMed ID: 11954661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
